• -

DIABECELL®

uses pig islets to replace human islets that have been destroyed by type 1 diabetes.

News & publications

Get the latest information from Diatranz Otsuka Ltd and find out what others are saying about us.

— 3 October 2016

Publications

Click on read more at right for a full list of publications.

Read More Read Less
Load More

— 3 October 2016

Data from the Argentine (DIA09) Clinical Trial published

Two articles relating to DIABECELL and the Argentine DIA09 clinical study have been published titled "Clinical Benefit of Islet Xenotransplantation for the Treatment of Type 1 Diabetes" and "No PERV transmission during a clinical trial of pig islet cell transplantation".

Read More Read Less

— 25 August 2016

Update on Southland pig facility

Diatranz Otsuka Limited (DOL) is currently undertaking a consultation process which proposes closing the Southland pig facility.

 

While we are working through the employment process with the 5 full-time and 2 part-time employees, no final decision has been made.

 

Further development of DIABECELL will take place in the United States.

 

Should the decision be made to close the facility we will work with Southern Heirloom Breeds Trust to rehome the 33 pigs.

Read More Read Less
Load More
Publications
Events

— 3 October 2016

Publications

Click on read more at right for a full list of publications.

Read More Read Less
Load More
Sector news

— 3 October 2016

Data from the Argentine (DIA09) Clinical Trial published

Two articles relating to DIABECELL and the Argentine DIA09 clinical study have been published titled "Clinical Benefit of Islet Xenotransplantation for the Treatment of Type 1 Diabetes" and "No PERV transmission during a clinical trial of pig islet cell transplantation".

Read More Read Less

— 25 August 2016

Update on Southland pig facility

Diatranz Otsuka Limited (DOL) is currently undertaking a consultation process which proposes closing the Southland pig facility.

 

While we are working through the employment process with the 5 full-time and 2 part-time employees, no final decision has been made.

 

Further development of DIABECELL will take place in the United States.

 

Should the decision be made to close the facility we will work with Southern Heirloom Breeds Trust to rehome the 33 pigs.

Read More Read Less
Load More